- Home
- REPX vs QDEL Comparison
REPX vs QDEL Comparison
Compare REPX & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REPX | QDEL |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 963.9M | 989.5M |
| IPO Year | 2003 | 2022 |
Fundamental Metrics
Financial Performance| Metric | REPX | QDEL |
|---|---|---|
| Price | $41.06 | $10.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $46.00 | $14.67 |
| AVG Volume (30 Days) | 289.8K | ★ 1.1M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | ★ 78.17 | 45.35 |
| EPS | ★ 0.80 | N/A |
| Revenue | $3,038,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $52.25 | N/A |
| Revenue Next Year | $6.87 | $1.85 |
| P/E Ratio | $50.05 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.08 | $9.92 |
| 52 Week High | $45.31 | $35.58 |
Technical Indicators
Market Signals| Indicator | REPX | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 34.12 |
| Support Level | $32.27 | $10.12 |
| Resistance Level | $41.39 | $12.85 |
| Average True Range (ATR) | 1.37 | 0.53 |
| MACD | -0.55 | 0.07 |
| Stochastic Oscillator | 7.12 | 11.23 |
Price Performance
Historical ComparisonAbout REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations include: The Permian Basin is an oil and natural gas producing area located in West Texas.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.